Inflammatory Breast Cancer
Editat de Jaime G. de la Garza-Salazar, Abelardo Meneses-Garcia, Claudia Arce-Salinasen Limba Engleză Hardback – 9 oct 2012
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 699.70 lei 38-44 zile | |
SPRINGER LONDON – 23 aug 2016 | 699.70 lei 38-44 zile | |
Hardback (1) | 1080.82 lei 6-8 săpt. | |
SPRINGER LONDON – 9 oct 2012 | 1080.82 lei 6-8 săpt. |
Preț: 1080.82 lei
Preț vechi: 1137.71 lei
-5% Nou
Puncte Express: 1621
Preț estimativ în valută:
206.84€ • 215.49$ • 171.98£
206.84€ • 215.49$ • 171.98£
Carte tipărită la comandă
Livrare economică 10-24 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780857299901
ISBN-10: 0857299905
Pagini: 145
Ilustrații: XV, 145 p.
Dimensiuni: 178 x 254 x 15 mm
Greutate: 0.54 kg
Ediția:2013
Editura: SPRINGER LONDON
Colecția Springer
Locul publicării:London, United Kingdom
ISBN-10: 0857299905
Pagini: 145
Ilustrații: XV, 145 p.
Dimensiuni: 178 x 254 x 15 mm
Greutate: 0.54 kg
Ediția:2013
Editura: SPRINGER LONDON
Colecția Springer
Locul publicării:London, United Kingdom
Public țintă
Professional/practitionerCuprins
1. Introduction.- 2. Breast Cancer: Epidemiological Panorama and Opportunities for Prevention.- 3. Pathology of Inflammatory Breast Cancer.- 4. Inflammatory Breast Cancer. Clinical Presentation, Diagnosis, Staging Evaluation, Differential Diagnosis, Surgical Treatment, and Follow-up.- 5. Imaging.- 6. Chemotherapy.- 7. Radiotherapy in Inflammatory Breast Cancer.- 8. Recurrent Inflammatory Breast Carcinoma: Prevalence, Patterns of Recurrence, and Therapeutic Approach.- 9. The Molecular Biology of Inflammatory Breast Cancer.- 10. Target Therapy in Inflammatory Breast Cancer.- 11. Follow-Up In Inflammatory Breast Cancer.
Recenzii
From the reviews:
“This book describes the clinical presentation, epidemiology, biology, outcome, and multimodality treatment of inflammatory breast cancer. … This book is written for medical professionals involved in the care of patients with inflammatory breast cancer, including surgeons and medical and radiation oncologists.” (Ingrid M. Lizarraga, Doody’s Book Reviews, May, 2013)
“This book describes the clinical presentation, epidemiology, biology, outcome, and multimodality treatment of inflammatory breast cancer. … This book is written for medical professionals involved in the care of patients with inflammatory breast cancer, including surgeons and medical and radiation oncologists.” (Ingrid M. Lizarraga, Doody’s Book Reviews, May, 2013)
Textul de pe ultima copertă
Inflammatory breast cancer is a rare and aggressive form of breast cancer that occurs in women of all ages, and, rarely, in men. Variable disease presentation means that this disease is often undetected and patients with this diagnosis have a poor prognosis.
Inflammatory Breast Cancer brings together the existing clinical information on inflammatory breast cancer. The content covers epidemiology, risk factors, diagnosis, histopathology and staging, therapy and management of patients with this disease. Recent advances in therapy have improved the prognosis of this type of cancer considerably, making this text a timely addition to the literature.
This book is an essential tool for medical, surgical and clinical oncologists specialising in breast cancer, who will inevitably encounter this rare but pernicious disease.
Inflammatory Breast Cancer brings together the existing clinical information on inflammatory breast cancer. The content covers epidemiology, risk factors, diagnosis, histopathology and staging, therapy and management of patients with this disease. Recent advances in therapy have improved the prognosis of this type of cancer considerably, making this text a timely addition to the literature.
This book is an essential tool for medical, surgical and clinical oncologists specialising in breast cancer, who will inevitably encounter this rare but pernicious disease.
Caracteristici
Covering all aspects of inflammatory breast cancer, this book provides valuable information not easily accessed anywhere else Authored by an expert team from the Instituto Nacional de Cancerología in Mexico Edited by international authorities on this rare but pernicious disease Includes supplementary material: sn.pub/extras